Drug Topics

FEBRUARY 18, 2025

Patients prescribed high-dose opioids were given the option to switch to buprenorphine in hopes of improving pain and reducing opioid dosage.

Dosage 593

Dosage 593

STAT

FEBRUARY 18, 2025

Biogen and Stoke Therapeutics have signed a partnership agreement to co-develop and sell Stoke’s experimental treatment for Dravet syndrome, a severe form of epilepsy, outside the U.S., the companies said Tuesday.  For Biogen, acquiring international commercial rights to the Stoke drug bolsters its rare disease and neurology pipeline, and provides another product that could help it return to growth in the latter part of the decade.

92

92

Drug Topics

FEBRUARY 18, 2025

Patients with musculoskeletal pain were treated with cryotherapy spray to assess its use in providing immediate and sustained pain relief.

247

247

STAT

FEBRUARY 18, 2025

California officials were dealt a setback by a federal judge who ruled that a controversial law banning so-called pay-to-delay deals between pharmaceutical companies is, in part, unconstitutional and so cannot be enforced against agreements that had no link to the state. In his ruling , U.S. District Court Judge Troy Nunley determined that the state law, which was enacted in 2019, violated the Dormant Commerce Clause of the U.S.

Pharmaceutical Companies 84

Pharmaceutical Companies Pharmaceutical Companies 84

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

FEBRUARY 18, 2025

Explore key legislative actions changing pharmacy practice in 2025 and beyond.

247

247

PharmaVoice

FEBRUARY 18, 2025

Scribe Therapeutics hopes to prevent cardiometabolic diseases by targeting underlying causes with CRISPR technology.

148

148

Pharmacy Times

FEBRUARY 18, 2025

Research suggests H5N1 may be spreading undetected among humans, particularly in veterinarians with frequent animal exposure.

122

122

Drug Topics

FEBRUARY 18, 2025

Previously, dupilumab (Dupixent) received orphan drug designation for bullous pemphigoid.

FDA 190

FDA 190

Pharmacy Times

FEBRUARY 18, 2025

New data from the longest known trial of pediatrics and adolescents in the postacute phase of COVID-19 show they are at a heightened risk of gastrointestinal tract symptoms.

121

121

STAT

FEBRUARY 18, 2025

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds.  Sign up here. Good morning, we’ve got a lot to go over. As one editor put it on Friday: “‘When it rains it pours’ doesn’t seem to adequately capture the deluge of news.

115

115

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Fierce Healthcare

FEBRUARY 18, 2025

At ViVE 2025, digital health leaders reveal new generative AI products and industry cost savings reports. Here's a look at some quick hits from the show floor.

114

114

Pharmaceutical Technology

FEBRUARY 18, 2025

As Sanofi and Regeneron await the FDA decision, a legal dispute between the partners over commercialisation details continues.

FDA 105

FDA 105

Fierce Healthcare

FEBRUARY 18, 2025

The quarterly numbers are a dip from the year prior and come shortly after news of mass layoffs among nonclinical employees. Alongside more than $200 million of expected savings per year, management said the cuts would "improve efficiency" and "empower staff.

104

104

pharmaphorum

FEBRUARY 18, 2025

The FDA is scheduled to deliver a verdict on Sanofi and Regeneron's Dupixent for rare autoimmune skin disorder bullous pemphigoid in June

FDA 98

FDA 98

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Fierce Healthcare

FEBRUARY 18, 2025

The order directs the Domestic Policy Council to make policy recommendations to protect IVF access and aggressively reduce the associated costs for treatment.

93

93

Pharmacy Times

FEBRUARY 18, 2025

Clinical decision support systems based on algorithms have improved outcomes and reduced costs in other health care settings.

83

83

pharmaphorum

FEBRUARY 18, 2025

ALS candidates from Biohaven, Prilenia, Clene, and UCB were unable to slow disease progression in the study, but two showed signs of efficacy

80

80

Pharmacy Times

FEBRUARY 18, 2025

Although larsucosterol did not show statistical significance, it showed clinically meaningful trends in 90-day mortality in patients with severe alcohol-associated hepatitis.

82

82

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

pharmaphorum

FEBRUARY 18, 2025

Sanofi has claimed FDA approval for the first biosimilar of Novo Nordisk's rapid-acting insulin analogue Novolog

FDA 76

FDA 76

Fierce Healthcare

FEBRUARY 18, 2025

Executives at Risant Health and Geisinger Health offered a look under the hood during a fireside chat at ViVE 2025 and shared details about the value-based "engine" that drives its work.

75

75

Pharmacy Times

FEBRUARY 18, 2025

Prescribing and dosing appropriate treatments for patients with sickle cell disease while managing episodes of acute pain are some of the integral roles of pharmacists.

73

73

Pharmaceutical Technology

FEBRUARY 18, 2025

The FDA has accepted Gileads new drug application with a decision expected by 19 June 2025.

FDA 71

FDA 71

Pharmaceutical Commerce

FEBRUARY 18, 2025

In the first part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Laura Johnson, senior director of sales, life sciences, Loftware, comments on why she believes supply chain collaboration is becoming increasingly critical today.

69

69

STAT

FEBRUARY 18, 2025

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Morning. Today we take a closer look at what firings at U.S. health agencies mean for the country’s broader scientific enterprise. Also, a hearty congrats to my coworkers Bob Herman, Tara Bannow, Casey Ross, and Lizzy Lawrence, who won a Polk award — STAT’s third — for their coverage of UnitedHealth Group.

63

63

pharmaphorum

FEBRUARY 18, 2025

Shionogi will market the EndeavorRide app, originally licensed from Akili, in Japan following its approval by the MHLW regulator

59

59

Pharmaceutical Technology

FEBRUARY 18, 2025

The US FDA has granted fast track designation to Rznomics' RZ-001 for the treatment of hepatocellular carcinoma (HCC).

FDA 59

FDA 59

Pharmacy Times

FEBRUARY 18, 2025

Second-line and later treatment options for small cell lung cancer are limited.

56

56

Pharmaceutical Technology

FEBRUARY 18, 2025

HMRI has signed a memorandum of understanding (MoU) with Novartis Australia for expediting medical research to drive healthcare projects.

59

59

PharmD Live

FEBRUARY 18, 2025

WASHINGTON, February 18, 2025 PharmD Live , an innovative pharmacist-led virtual care solution powered by AI-driven algorithms, announces the release of its recent white paper, Maximizing Shared Savings for Payviders: ACOs, IDNs, At-Risk Provider Groups and Clinics. The paper demonstrates how clinical pharmacist-led virtual care improves medication adherence, reduces hospital readmissions and enhances value-based care metrics, driving financial and clinical success for healthcare organizations.

Hospitals 52

Hospitals Patient Care 52

PharmExec

FEBRUARY 18, 2025

Ospomyv, a biosimilar to Prolia, is indicated for postmenopausal women and men at high risk of fracture, while Xbryk, a biosimilar to Xgeva, is indicated for preventing skeletal-related events in multiple myeloma and solid tumor bone metastases.

FDA 52

FDA 52

pharmaphorum

FEBRUARY 18, 2025

Join us at the 3rd Obesity & Weight Loss Summit by Hanson Wade on July 14-16, 2025, in Boston, MA. This event brings together experts and professionals in the field of obesity and weight loss to share insights and advancements in the industry. Register now to secure your spot!

52

52

Pharmaceutical Commerce

FEBRUARY 18, 2025

The latest news for pharma industry insiders.

52

52

pharmaphorum

FEBRUARY 18, 2025

Join us at the 2nd ADC Payload Summit from May 6-8 in Boston, MA, organised by Hanson Wade. This event will feature industry experts and thought leaders sharing insights on the latest trends and developments in the field.

52

52